학술논문
국소진행 두경부 상피세포암에서 선행유도약물요법 후 보조약물요법의 효과
이용수 9
- 영문명
- The Effect of Adjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma after Induction Chemotherapy
- 발행기관
- 대한두경부종양학회
- 저자명
- 김철우 노재경 안중배 박준오 정소영 이석 이혜란 이경희 정현철 김주항 김병수 서창옥 김귀언 최은창 홍원표 박정수 차인호 이충국 최진혁
- 간행물 정보
- 『대한두경부종양학회지』제10권 제1호, 13~24쪽, 전체 12쪽
- 주제분류
- 의약학 > 종양학
- 파일형태
- 발행일자
- 1994.06.30
4,240원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
Despite optimal local therapy such as surgery and/or radiotherapy, the long term outcome is poor for patients with advanced squamous cell carcinomma of head and neck, due to frequent loco-regional recurrence and distant metastases. We studied to determine whether the combination chemotherapy, especially as an adjuvant chemotherapy, would improve the survival of these patients.
Between January, 1986 and December, 1992, 57 patients with previously untreated, locally advanced squamous cell arcinoma of head and neck were assigned to receive 2-3 cycles of induction chemotherapy consisting of 5-fluorouracil(F) and cisplatin(P) every 3 weeks and standard local therapy such as surgery and/or radiotherapy followed by adjuvant chemotherapy with the same FP regimens. Of the 57 enroled patients, 45 patients were evaluable. The obtained results were as following:
1) Among 45 evaluable patients, 18 patients finished all treatment protocol including adjuvant chemotherapy and 27 patients had no adjuvant chemotherapy. The difference of age, sex, performance status, disease stage, and tumor differentiation was not significant statistically between adjuvant chemotherapy group and no-adjuvant chemotherapy group.
2) After induction chemotherapy, 7/45(15.4%), 30/45(67%) achieved complete remission and partial remission respectively with 82.4% overall response rates in entire patients.
3) The 4year progression free survival was 43.3% in adjuvant chemotherapy group and 24.1% in no-adjuvant chemotherapy group(p>0.05). The 4year overall survival was 56.9% and 25.5% respectively(p>0.05). There was no significant different in the patterns of local recurrence and distant metastasis between the two groups.
4) Adverse reactions from combination chemotherapy included nausea, vomiting, mucositis, diarrhea and hematologic bone marrow depression. These were mild and tolerated by patients, and these was no episode of any life threatening toxicities.
In conclusion, adjuvant chemotherapy after induction chemotherapy and local therapy did not show statistically significant survival improvement, but there was trend of prolongation of survival when compared to no adjuvant chemotherapy. Thus, large scale phase III randomized controlled studies are strongly recommended.
목차
Abstract
서론
대상 및 연구방법
결과
고안
결론
References
해당간행물 수록 논문
- 기무라병의 임상특성과 치료성적
- 국소진행 두경부 상피세포암에서 선행유도약물요법 후 보조약물요법의 효과
- A Clinical Study on Tumors of the Parapharyngeal Space
- 타액선 종양의 임상적 고찰
- 두경부 편평세포암종에 대한 UFT 투여 후 항종양효과에 관한 제2상 임상 연구
- 두경부 영역에서 연골성 종양 치험례
- Analysis of Intraoral Squamous Cell Carcinoma Reconstructed with Radial Forearm Flap
- 두경부 종양환자에서 경부 림프절의 예기치 않은 병리적 소견
- 소타액선 종양에 관한 임상적 고찰
- 원발성 부갑상선 기능항진증에 대한 임상적 고찰
참고문헌
관련논문
의약학 > 종양학분야 BEST
- 방사선 치료에 내성이 유도된 두경부 편평세포암에 대한 종양살상 헤르페스 바이러스의 유전자 치료 효과
- 식도암에서 근치적 절제술 후 방사선치료의 역할
- 인유두종바이러스 관련 질환의 예방을 위한 남성 대상 백신의 임상적 유용성
의약학 > 종양학분야 NEW
- Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
- Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
- Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!